Literature DB >> 9788300

Altered rhodopsin regeneration in diabetic mice caused by acid conditions within the rod photoreceptors.

S E Ostroy1.   

Abstract

PURPOSE: The experiments were designed to provide details on the characteristics of rhodopsin regeneration in the rod photoreceptors of diabetic mice and to evaluate their mechanistic basis.
METHODS: A genetically-derived diabetic albino mouse was developed. An excised albino mouse eye preparation was used. The preparation allows for direct measurements of rhodopsin concentration and other spectrally distinct intermediates, and maintains the structural integrity of the compartments involved in rhodopsin regeneration. The experiments were conducted at moderate bleaching levels, averaging 13-14%, with mice that exhibited moderate levels of blood glucose concentration.
RESULTS: Rhodopsin regeneration was delayed in both genetically-derived and streptozotocin-injected diabetic mice when compared to non-diabetic mice. During the delay an intermediate of rhodopsin, N-Retinylidene Opsin (NRO440), that precedes the hydrolysis of the bleached chromophore from the opsin and that is associated with acidic conditions was observed. This intermediate was not observed in non-diabetic mice. The delay in rhodopsin regeneration of the diabetic mice was partially eliminated, and the relative concentration of NRO440 was decreased, when the internal pH of the rod photoreceptor was raised by modifying the perfusate composition.
CONCLUSIONS: Following a bleach, both genetic and streptozotocin diabetic mice exhibited abnormalities in rhodopsin regeneration. When studied at moderate bleaching levels with animals that were moderately diabetic, both groups of diabetic mice exhibited a delay in the start of the rhodopsin regeneration. The delay appears to be caused by the formation of an acid intermediate of the bleached rhodopsin resulting from acid conditions within the rod photoreceptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788300     DOI: 10.1076/ceyr.17.10.979.5236

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  Systemic Retinaldehyde Treatment Corrects Retinal Oxidative Stress, Rod Dysfunction, and Impaired Visual Performance in Diabetic Mice.

Authors:  Bruce A Berkowitz; Timothy S Kern; David Bissig; Priya Patel; Ankit Bhatia; Vladimir J Kefalov; Robin Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

2.  Oscillatory potentials and the b-Wave: partial masking and interdependence in dark adaptation and diabetes in the rat.

Authors:  C J Layton; R Safa; N N Osborne
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-31       Impact factor: 3.117

3.  Development of an MRI biomarker sensitive to tetrameric visual arrestin 1 and its reduction via light-evoked translocation in vivo.

Authors:  Bruce A Berkowitz; Jawan Gorgis; Ankit Patel; Faiza Baameur; Vsevolod V Gurevich; Cheryl M Craft; Vladimir J Kefalov; Robin Roberts
Journal:  FASEB J       Date:  2014-10-28       Impact factor: 5.191

Review 4.  Preventing diabetic retinopathy by mitigating subretinal space oxidative stress in vivo.

Authors:  Bruce A Berkowitz
Journal:  Vis Neurosci       Date:  2020-06-15       Impact factor: 3.241

5.  Acute systemic 11-cis-retinal intervention improves abnormal outer retinal ion channel closure in diabetic mice.

Authors:  Bruce A Berkowitz; David Bissig; Priya Patel; Ankit Bhatia; Robin Roberts
Journal:  Mol Vis       Date:  2012-02-07       Impact factor: 2.367

Review 6.  Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.

Authors:  Deoye Tonade; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2020-11-12       Impact factor: 19.704

Review 7.  Photoreceptors in diabetic retinopathy.

Authors:  Timothy S Kern; Bruce A Berkowitz
Journal:  J Diabetes Investig       Date:  2015-01-07       Impact factor: 4.232

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.